148 related articles for article (PubMed ID: 32110095)
1. Contrast-Enhanced CT Parameters of Gastric Adenocarcinoma: Can Radiomic Features Be Surrogate Biomarkers for HER2 Over-Expression Status?
Wang N; Wang X; Li W; Ye H; Bai H; Wu J; Chen M
Cancer Manag Res; 2020; 12():1211-1219. PubMed ID: 32110095
[TBL] [Abstract][Full Text] [Related]
2. The Preoperative Enhanced Degree of Contrast-enhanced CT Images: A Potential Independent Predictor in Gastric Adenocarcinoma Patients After Radical Gastrectomy.
Wang X; Ye H; Yan Y; Wu J; Wang N; Chen M
Cancer Manag Res; 2020; 12():11989-11999. PubMed ID: 33262649
[TBL] [Abstract][Full Text] [Related]
3. Predicting human epidermal growth factor receptor 2 status of patients with gastric cancer by computed tomography and clinical features.
Li Y; Dai WG; Lin Q; Wang Z; Xu H; Chen Y; Wang J
Gastroenterol Rep (Oxf); 2024; 12():goae042. PubMed ID: 38726026
[TBL] [Abstract][Full Text] [Related]
4. Value of CagA, HER2, ALDH1, and KiSS-1 in predicting metastasis and prognosis for gastric adenocarcinoma.
Lu G; Wang X; Wang Y; Cheng Z; Zhou L
Int J Clin Exp Pathol; 2018; 11(7):3628-3637. PubMed ID: 31949743
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of volume-based parameters using
Park JS; Lee N; Beom SH; Kim HS; Lee CK; Rha SY; Chung HC; Yun M; Cho A; Jung M
Gastric Cancer; 2018 Mar; 21(2):213-224. PubMed ID: 28643145
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of Human epidermal growth factor receptor-2 expression in patients with resectable gastric adenocarcinoma.
Kim H; Seo S; Kim K; Park YH; An M; Baik H; Choi C; Oh S
World J Surg Oncol; 2019 Jul; 17(1):122. PubMed ID: 31296222
[TBL] [Abstract][Full Text] [Related]
7. Human Epidermal Growth Factor Receptor 2 Expression in Unresectable Gastric Cancers: Relationship with CT Characteristics.
Lee JS; Kim SH; Im SA; Kim MA; Han JK
Korean J Radiol; 2017; 18(5):809-820. PubMed ID: 28860898
[TBL] [Abstract][Full Text] [Related]
8. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
[TBL] [Abstract][Full Text] [Related]
9. Relationship Between 18F-FDG PET/CT Findings and HER2 Expression in Gastric Cancer.
Chen R; Zhou X; Liu J; Huang G
J Nucl Med; 2016 Jul; 57(7):1040-4. PubMed ID: 26966162
[TBL] [Abstract][Full Text] [Related]
10. Prediction of HER2 expression in breast cancer by combining PET/CT radiomic analysis and machine learning.
Chen Y; Wang Z; Yin G; Sui C; Liu Z; Li X; Chen W
Ann Nucl Med; 2022 Feb; 36(2):172-182. PubMed ID: 34716873
[TBL] [Abstract][Full Text] [Related]
11. CT texture analysis of lung adenocarcinoma: can Radiomic features be surrogate biomarkers for EGFR mutation statuses.
Mei D; Luo Y; Wang Y; Gong J
Cancer Imaging; 2018 Dec; 18(1):52. PubMed ID: 30547844
[TBL] [Abstract][Full Text] [Related]
12. Correlation of breast cancer subtypes, based on estrogen receptor, progesterone receptor, and HER2, with functional imaging parameters from ⁶⁸Ga-RGD PET/CT and ¹⁸F-FDG PET/CT.
Yoon HJ; Kang KW; Chun IK; Cho N; Im SA; Jeong S; Lee S; Jung KC; Lee YS; Jeong JM; Lee DS; Chung JK; Moon WK
Eur J Nucl Med Mol Imaging; 2014 Aug; 41(8):1534-43. PubMed ID: 24652232
[TBL] [Abstract][Full Text] [Related]
13. Iodine Concentration in Spectral CT: Assessment of Prognostic Determinants in Patients With Gastric Adenocarcinoma.
Liang P; Ren XC; Gao JB; Chen KS; Xu X
AJR Am J Roentgenol; 2017 Nov; 209(5):1033-1038. PubMed ID: 28871809
[TBL] [Abstract][Full Text] [Related]
14. Contrast-enhanced cone beam breast CT features of breast cancers: correlation with immunohistochemical receptors and molecular subtypes.
Ma Y; Liu A; O'Connell AM; Zhu Y; Li H; Han P; Yin L; Lu H; Ye Z
Eur Radiol; 2021 Apr; 31(4):2580-2589. PubMed ID: 33009590
[TBL] [Abstract][Full Text] [Related]
15. [Application of radiomics captured from CT to predict the EGFR mutation status and TKIs therapeutic sensitivity of advanced lung adenocarcinoma].
Yang CS; Chen WD; Gong GZ; Li ZJ; Qiu QT; Yin Y
Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):282-287. PubMed ID: 31014053
[No Abstract] [Full Text] [Related]
16. Dual-energy CT quantitative parameters for evaluating Immunohistochemical biomarkers of invasive breast cancer.
Wang X; Liu D; Zeng X; Jiang S; Li L; Yu T; Zhang J
Cancer Imaging; 2021 Jan; 21(1):4. PubMed ID: 33413654
[TBL] [Abstract][Full Text] [Related]
17. Gastric poorly cohesive carcinoma: differentiation from tubular adenocarcinoma using nomograms based on CT findings in the 40 s late arterial phase.
Liu S; Qiao X; Ji C; Shi H; Wang Y; Li L; Zhou Z
Eur Radiol; 2021 Aug; 31(8):5768-5778. PubMed ID: 33569616
[TBL] [Abstract][Full Text] [Related]
18. Molecular subtype classification of breast cancer using established radiomic signature models based on
Liu J; Bian H; Zhang Y; Gao Y; Yin G; Wang Z; Li X; Ma W; Xu W
Front Biosci (Landmark Ed); 2021 Aug; 26(9):475-484. PubMed ID: 34590460
[No Abstract] [Full Text] [Related]
19. Comparison of radiomic features in diagnostic CT images with and without contrast enhancement in the delayed phase for NSCLC patients.
Kakino R; Nakamura M; Mitsuyoshi T; Shintani T; Hirashima H; Matsuo Y; Mizowaki T
Phys Med; 2020 Jan; 69():176-182. PubMed ID: 31918370
[TBL] [Abstract][Full Text] [Related]
20. Dual-Energy CT-Based Nomogram for Decoding HER2 Status in Patients With Gastric Cancer.
Zhao H; Li W; Huang W; Yang Y; Shen W; Liang P; Gao J
AJR Am J Roentgenol; 2021 Jun; 216(6):1539-1548. PubMed ID: 33852330
[No Abstract] [Full Text] [Related]
[Next] [New Search]
